Business

Covid-19: India frees export of anti-malarial drug Hydroxychloroquine

India on Thursday lifted the restriction on the export of anti-malarial drug Hydroxychloroquine, which is widely used around the world as a prophylactic to fight Covid-19.

migrator

New Delhi

In March, the Centre had imposed curbs on the export of Hydroxychloroquine and formulations used to manufacture the medicine.

According to a late night notification by the Ministry of Commerce and Industry, the export status of the medication and the composition ingredients have been changed from "prohibited" to "free".

The notification was issued by the Directorate General of Foreign Trade (DGFT).

India is a major exporter of Hydroxychloroquine, which has witnessed a surge in demand amid the novel coronavirus crisis.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Latest: Iranian-backed militias join fighting as conflict widens, intensifies

Middle East turmoil: Indian airlines cancel over 300 int'l flights on Mon

Modi-Carney talks: India, Canada seal landmark uranium deal; set USD 50 bn trade target

Madras High Court rejects plea seeking ban on goat, cattle slaughter in meat shops

Kauvery Hospitals opens dedicated GI bleed centres across Tamil Nadu, Karnataka